Picture of 2cureX AB logo

2CUREX 2cureX AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: 2Curex's Clinical Partner Presents Positive Results Of IndiTreat-Guided Clinical Trial

May 20 (Reuters) - 2cureX AB  2CUREX.ST :
    * 2CUREX'S CLINICAL PARTNER, UNIVERSITY HOSPITAL VEJLE,
PRESENTS
POSITIVE RESULTS OF THE INDITREAT®-GUIDED CLINICAL TRIAL IN
THIRD LINE METASTATIC COLORECTAL CANCER AT THE ASCO 2021 ANNUAL
MEETING
    * PRIMARY ENDPOINT OF TRIAL WAS MET
    * PRIMARY ENDPOINT WAS PROGRESSION FREE SURVIVAL (PFS) AFTER
8
WEEKS OF TREATMENT

Source text for Eikon:  ID:nWkr7pGFqX 
Further company coverage:  2CUREX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on 2cureX AB

See all news